Acromegaly is characterized by a hypersecretion of growth hormone and is frequently associated with valvular abnormality and arrhythmia. The increased morbidity and mortality is primarily caused by stroke and cardiovascular disease. Therefore, valve reconstruction and sinus rhythm recovery will be particularly beneficial. We report herein the successful surgical treatment of two patients with combined valvular insufficiency and chronic atrial fibrillation in the setting of acromegaly.
Get full access to this article
View all access options for this article.
References
1.
BengtssonBAEdenSErnestIOdenASjogrenB. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand1988;223:327–35.
2.
OndreycoSMLewisHDJrHartmanCR. Myxomatous degeneration and cystic medial necrosis associated with acromegaly. Arch Intern Med1980;140:547–9.
3.
OhtsukaGAomiSKoyanagiHTsukuiHTomizawaYHashimotoA. Heart valve operation in acromegaly. Ann Thorac Surg1997;64:390–3.
4.
ColaoASpinelliLMarzulloPPivonelloRPetrettaMdi SommaC. High prevalence of cardiac valve disease in acromegaly: An observational, analytical, case-control study. J Clin Endocrinol Metab2003;88:3196–201.
5.
CableDGDearaniJAO'BrienTOrszulakTAPugaFJSchaffHV. Surgical treatment of valvular heart disease in patients with acromegaly. J Heart Valve Dis2000;9:828–31.
6.
LimMJBarkanALBudaAJ. Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion. Ann Intern Med1992;117:719–26.
7.
Landin-WilhelmsenKTengbornLWilhelmsenLBengtssonBA. Elevated fibrinogen levels decrease following treatment of acromegaly. Clin Endocrinol (Oxf)1997;46:69–74.
8.
NakajimaHKobayashiJBandoKNiwayaKTagusariOSasakoY. The effect of cryo-maze procedure on early and intermediate term outcome in mitral valve disease: Case matched study. Circulation2002;106(12 Suppl 1):I46–I50.
